Understanding Comparative Effectiveness Through Real World Evidence Analytics

Aug 14, 2017

For the past couple of years, the healthcare industry has been witnessing relentless growth with major pharmaceutical companies offering advanced medications. Major organizations are highly relying on innovations to bring “pharmacies closer to their customer’s doorstep”. The growing prevalence of chronic diseases and the development of expensive clinical innovations are forcing organizations to look for promising resources such as real world analytics. Real world evidence analytics provides insights on how a drug or drug class performs in the real world medical settings. Through the deployment of real world analytics, organizations can lure healthcare information and analyze it to provide a clear description of treatment patterns, resource use, and the costs associated with treatments. Furthermore, real world analytics also enables organizations to compete, drive patient value, design more successful clinical trials, and quickly respond to ever-changing market dynamics.

Quantzig’s real-world analytics solution helps the client develop better therapies and differentiate their brand in the healthcare market. Also, the solution provides comprehensive insights on treatment pathways, patient adherence, disease progression, and pricing levels. The client can further evaluate their ROI and develop new strategies to enter niche segments.

Are your challenges holding you back from achieving better outcomes? Contact our real world evidence analytics experts for result-oriented, cost-effective solutions.

The Business Challenge

Traditional therapeutic practices were no longer effective in advanced pharmaceutical space. The manufacturers facing increasing costs and shrinking margins wanted to leverage the use of real-world evidence data to compare the cost and benefits of its drug against the competitors and their products. One major global manufacturer in the pharmaceutical space had a strong vision for the future to identify patient cohorts based on drug usage and clinical outcomes. The client was facing challenges in understanding the clinical outcomes in terms of clinical quality measures, readmissions, and length of stay.

Our Approach

competitive effectiveness

Explore our platform capabilities and learn more about its benefits by scheduling a FREE solution demo.

Real World Evidence Solution Benefits

  • Assess the quality and efficacy of each patient cohort
  • Develop an interactive report based on pre-defined parameters
  • Leverage the use of authoring tools to gauge information on patient profile and risk variables
  • Define and model statistical models and algorithms to validate readmission cases
  • Predict risk scores, confidence level, and risk coefficient

Real World Evidence Solution Predictive Insights

  • Utilize real world evidence to compare competing products in terms of quality and efficacy
  • Identify important patterns and associations to implement key use cases
  • Determine the unmet need by evaluating the cost of illness
  • Understand the treatment patterns and their effects on patient, clinical, and economic outcomes
  • Evaluate appropriateness of drug utilization

Want to know more about real world evidence analytics? Request more information from our analytics experts.

Related Articles:

Recent Case Studies


Our advanced analytics expertise spans across industries, sectors, and functions, which enables us to deliver robust, agile solutions to all our clients. These are our core competencies, formed through years of experience.


Our free resources shed light on our extensive expertise and equip you with information to accelerate decision-making, growth, and innovation.

Talk to us
Talk to us